Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva reaches proposed $4.35 billion settlement of U.S. opioid lawsuits
Teva Pharmaceuticals will pay $420 million in a federal case
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits | InvestorPlace
Teva lied about opioid role, New York says | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva may move court against Dr Reddy's for patent infringement | Mint
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva, Allergan enter into $58m opioid settlement with San Francisco
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to pay New York $500M for role in opioid crisis - POLITICO
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
